Press release
Segmentation Analysis, Market Trends, and Competitive Landscape in the Pancreatic Cancer Precision Medicine Market
Pancreatic Cancer Precision Medicine Market
Pancreatic Cancer Precision Medicine Market Size and Projected Growth
The pancreatic cancer precision medicine market is anticipated to expand rapidly in the coming years, reaching a valuation of $1.24 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 16.6%. Several factors contribute to this positive outlook, including increased adoption of precision oncology, rising investments in pancreatic cancer research, advances in diagnostic methods, growth in immunotherapy pipelines, and the expanding use of companion diagnostics. Key trends shaping the market include the growing application of genomic and molecular profiling, wider acceptance of biomarker-driven treatments, the development of targeted and immunotherapy combination therapies, increased use of liquid biopsies, and a stronger emphasis on personalized treatment plans.
Download a free sample of the pancreatic cancer precision medicine market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24354&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Top Companies Leading the Pancreatic Cancer Precision Medicine Market
The market is influenced by several prominent pharmaceutical and biotechnology companies, including Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca Plc, Novartis AG, Amgen Inc., Eli Lilly and Company, Genentech Inc., Ipsen Pharma, Bayer AG, Thermo Fisher Scientific Inc., Illumina Inc., Guardant Health, Foundation Medicine Inc., Oncolytics Biotech Inc., Erytech Pharma, PharmaCyte Biotech Inc., Celgene Corporation, and Natera Inc.
A significant development occurred in January 2024 when Bristol Myers Squibb acquired Mirati Therapeutics. This acquisition strengthens Bristol Myers Squibb's precision oncology portfolio by adding Mirati's targeted oncology assets, including the commercial KRAS G12C inhibitor Krazati (adagrasib) and its pipeline focusing on KRAS- and PRMT5-targeted therapies. Mirati Therapeutics is known for its expertise in developing precision oncology treatments for KRAS-mutant cancers, enhancing Bristol Myers Squibb's position in the field.
Emerging Trends and New Opportunities in Pancreatic Cancer Precision Medicine
Companies in this market are continuously advancing technologies designed to improve early detection and tumor profiling, which are critical for personalizing treatment strategies. One such development is the precision medical tool, a device that aids in the accurate diagnosis and treatment of diseases based on a patient's unique biological profile.
For example, in January 2024, Cedars-Sinai launched a molecular twin precision oncology platform aimed at predicting pancreatic cancer survival more effectively. This platform identifies crucial biomarkers using blood and tissue samples from 74 patients with pancreatic ductal adenocarcinoma. It offers a promising approach to guide treatment decisions, especially in resource-limited settings, making precision oncology more accessible and precise.
View the full pancreatic cancer precision medicine market report:
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-precision-medicine-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Breakdown of Market Segments in Pancreatic Cancer Precision Medicine
This market is segmented based on therapeutic approaches, diagnostic technologies, and applications. The therapeutic approach categories include targeted therapy, immunotherapy, chemotherapy-precision combinations, and other innovative therapies. Diagnostic technologies cover genomic testing, molecular diagnostics, liquid biopsy, biomarker-based companion diagnostics, and other diagnostic tools. Application areas span hospitals, specialty clinics, academic and research institutes, and diagnostic centers.
Within these broader categories, subsegments further refine the market. Targeted therapy includes kinase inhibitors and PARP inhibitors. Immunotherapy encompasses immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapy. Chemotherapy-precision combinations are broken down into gemcitabine-based, fluorouracil-based, and nab-paclitaxel-based combinations. Other therapeutic approaches involve RNA-based therapies, epigenetic modulators, and antibody-drug conjugates (ADCs).
New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segmentation Analysis, Market Trends, and Competitive Landscape in the Pancreatic Cancer Precision Medicine Market here
News-ID: 4596343 • Views: …
More Releases from The Business Research Company
Construction Schedule Software Market Outlook Signals Expansion To $2.29 Billion …
The construction schedule software sector has seen significant growth in recent years, driven by increasing demands for efficient project management in the construction industry. As construction projects become more complex and digital transformation accelerates, this market is set to continue expanding steadily over the coming decade. Let's explore the market size, key players, current trends, and segmentation to get a clear picture of what lies ahead.
Steady Rise in Construction Schedule…
Confidential-Compute Display-Server Market Report 2026 Market Outlook Supported …
The confidential-compute display-server market is experiencing remarkable growth driven by the increasing need for secure remote work environments and robust data protection. As cyber threats become more sophisticated, enterprises are turning to advanced virtualization and cloud technologies to safeguard sensitive information. This analysis explores the current market size, key players, emerging trends, and detailed segmentation of this rapidly evolving industry.
Forecasted Expansion of the Confidential-Compute Display-Server Market
The confidential-compute display-server…
Compute Express Link (CXL) Memory-Appliance Market Insights Highlight Segment Ex …
The Compute Express Link (CXL) memory-appliance market has witnessed remarkable growth in recent years, driven by rapid advancements in data-intensive technologies and increasing demand for enhanced computing performance. As industries increasingly rely on sophisticated memory solutions to support AI, machine learning, and cloud infrastructures, the market is set for substantial expansion in the coming years. Let's explore the current market size, key players, emerging trends, and segmentation to understand the…
Configuration Management Software Market Report Examines Leading Companies And G …
The configuration management software market is witnessing remarkable growth as organizations increasingly seek efficient ways to handle complex IT environments. With evolving technological demands and expanding cloud adoption, this sector is set for significant expansion through 2030. Let's explore the current market size, key drivers, leading companies, and emerging trends shaping the future of configuration management software.
Configuration Management Software Market Size and Growth Outlook
The configuration management software market…
More Releases for Medicine
Health & Medicine
New Delhi, India - July 16, 2026
On the sacred day when Lord Jagannath leaves the sanctum of his temple and begins his Rath Yatra, DialysisOnGo, an initiative by Pashupati Nephrology Care Pvt. Ltd., today announced its national launch.
Just as the Lord comes out to move among his people, DialysisOnGo empowers dialysis patients to step out of their homes and reclaim a life of movement. The platform connects patients with verified,…
Empowering Medicine through Student Nonprofit: Medicine Community & Research
Image: https://www.abnewswire.com/uploads/be780e491a4ae6bc377728149d5124cc.png
(MCR's Logo by Jason Jiang)
Many students dream of leading thousands and creating an impact in their community.
Among these are Quang La (Founder), Adhrith (Co-founder), and Heymin Han (Co-founder) who came together to create Medicine Community & Research, a 501c3 nonprofit organization fiscally sponsored by The Hack Foundation.
The mission of MCR revolves around 3 key things, a student community, a spread of medicine articles, and an organization that advocates for…
Herbal Medicine Market 2019-2025: Market By Development, Regional Sales, Regiona …
In a recent study published by QY Research, titled Herbal Medicine, analysts offers an in-depth analysis of global Herbal Medicine market. The study analyses the various aspect of the market by studying its historic and forecast data. The research report provides Porters five force model, SWOT analysis, and PESTEL analysis of the market. The different areas covered in the report are market size, drivers and restrains, segment analysis, geographic outlook,…
Tropical Medicine
Tropics are the most diverse regions on the earth . A large number of population live in this region where the weather varies throughout the year ( from scorching summer to chilly winter).This changing seasons induce the outbreaks of some fetal diseases known as tropical diseases which is unique only to the tropical areas.
Malaria, Tuberculosis & AIDS are the major ones .Lack of sanitation, personal hygiene, proper…
Sports Medicine Market 2018 | Top Most Players | Medstar Sports Medicine, Muelle …
Competitive Insights:
The Sports Medicine Market is dominated by a few large players such as Arthrex, Inc, Smith & Nephew, DePuy Mitek Inc, and Stryker Corporation, who have consolidated the market controlling a share of more than 70% in 2016. These players consistently introduce innovative and technologically advanced products in the market to ensure a competitive advantage over the other players. Some other players operating in this industry are Medstar Sports…
Indian Medicine
Dr.JRK's Siddha Research and Pharma is the herbal medicine in India, and has been in the business of good manufacturing practices. We strongly believing in intellectual asset creation through discovery, documentation and development of Indian systems of medicine. G7 capsules is the solution for Allergic Disorders the herbal medicine in Inida. Atopy or hyper sensitivity is the major problem in all countries, the problem manifest in multifold ways such as…
